Investors provide capital to companies, which then provide dividends and returns to investors. Banks help investors value ...

Tesla stock (NASDAQ:TSLA) has gained close to 20% over the past month. This rally is partly driven by a broader market upswing, but a more crucial factor has been CEO Elon Musk’s renewed focus on ...

Apple is still around a $3 trillion market cap despite its poor start this year. But with a lower valuation, it's trading at ...

That's great news for Nvidia and other frontline players in the AI/data center industry. It's also great news for some of the ...

About This EventThe 2025 Global Retail Executive Forum visits the Nasdaq MarketSite in Times Square. The event brings together industry leaders from across the globe to share insights and discuss the ...

About This EventCare.com (Nasdaq: IAC), one of the largest online marketplaces to find family care and care jobs, visits the Nasdaq MarketSite in Times Square.In honor of the occasion, Brad Wilson, ...

Back in 2022, billionaire Stanley Druckenmiller made a sizable bet on chipmaker Nvidia. The company has gone on to become one ...

Oskar Bosson, VP and Head of Investor Relations and Communications at BioArctic, shares the company’s mission to combat neurodegenerative diseases like Alzheimer’s, Parkinson’s, and ALS. Oskar ...

So, for all countries, they find that a 10% increase in the market cap ratio leads to a 0.028% increase in long-run economic growth, while for high-income countries alone, it leads to a 0.045% ...

Nasdaq Verafin is embarking on a strategic collaboration with sanctions screening provider Fincom to bring more robust sanctions screening technology to clients. Sanctions screening is an ...

About This EventNasdaq ISE (Nasdaq: ISE), formerly International Securities Exchange Holdings, Inc., which launched in May 2000 as the first all-electronic options exchange in the U.S. (acquired by ...

Gubra is a highly specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. In this interview, CEO Henrik Blou reflects on Gubra’s ...